Whale season kicks off on Brazil coast Often sighted in the period are the killer whale and the humpback whale Whale season started this month on the Brazilian coast and is expected to last until November. Projeto ProFranca Director Karina Groch reported that, for right whales, the season started a little early. The first specimens were reported on June 12. “Since then, the number has been on the rise,” Groch said. On Friday (Jul. 16), hovering over the coast of Santa Catarina state, south Brazil, researchers sighted more whales in the region than the whole month of September last year. “This is a sign that we’re likely to see a season with a higher number of whales than last year,” the biologist argued.
Investing in whaling companies does not seem prudent. Bad juju. Hopefully the UFOs will scare them off. No need to hunt whales.
STONEY!!!!! It's a good day to add some Yum China to the retirement account. YUMC----> $40 (-10%) $38.73 would be a good limit order.
Antero Resources Likes to bounce off its 200 day. Big volume last week. If the GOP sweeps the House and Senate.... those Nov $35 calls will be 4 baggers. AR----> $32.93 Antero Resources Corporation is an independent oil and natural gas company engaged in the exploration, development, and production of natural gas, NGLs, and oil properties located in the Appalachian Basin. Headquartered in Denver, Colorado, we are focused on creating value through the development of our large portfolio of repeatable, low cost, liquids-rich drilling opportunities in two of the premier North American shale plays, the Marcellus and the Utica shales. Due to its market leading firm transportation portfolio and midstream ownership through Antero Midstream, Antero is the most integrated NGL and natural gas business in the U.S.
good Morning-- I have to be quick today many responsibilities in the sports blogging world and a Vet appointment... Check dem' anal glands! Overnight is back! ---> But where is the apology? Each Day I send the HF a list of Daily actionable stocks---- I do not know which of these they will buy for me depends on how they get out of the gate******* THE LIST MONDAY A) BUY FLYW Flywire initiated with a Buy at Loop Capital 05:46 FLYW Loop Capital analyst Hal Goetsch initiated coverage of Flywire with a Buy rating and $25 price target. B) Jump Back in the WOLF trade- BUY WOLF Wolfspeed upgraded to Overweight into investor day at JPMorgan C) Buy AMLX Amylyx price target raised to $50 from $35 at H.C. Wainwright D) Buy Ollie Bargain Bin Ollie's Bargain Outlet initiated with a Buy at Gordon Haskett 06:16 OLLI E) Buy Nutanix Nutanix price target raised to $33 from $26 at KeyBanc 06:17 NTNX KeyBanc analyst Thomas Blakey raised the firm's price target on Nutanix to $33 from $26 to reflect increased confidence in his re-rating thesis, in line with peer multiples on an EV/Sales multiples at 4-times 2023 sales and a discount to 5.1-times near-term average for the overall universe. The analyst notes survey data from 35 VARs and channel partners indicated strong Q3 results and a stable outlook for 2022/2023 IT budget growth. However, the survey showed macro impact picking up, Blakey adds. He keeps an Overweight rating on the shares. F) Buy Stoke Therapeutics Stoke Therapeutics upgraded to Outperform from Market Perform at SVB Securities 06:18 STOK SVB Securities analyst Rudy Li upgraded Stoke Therapeutics to Outperform from Market Perform with a $30 price target. G) Buy We Work WeWork initiated with an Overweight at Cantor Fitzgerald 06:21 WE Cantor Fitzgerald analyst Brett Knoblauch initiated coverage of WeWork with an Overweight rating and $8 price target. WeWork is nearing the tail-end of a multi-year cost rationalization and real estate footprint optimization strategy, which has already resulted in removing $2.7B in costs from the business, Knoblauch tells investors in a research note. Demand for flexible workspace has remained robust post-pandemic, and the analyst believes the shift away from traditional office lease strategies by enterprises will act as a decade-long tailwind. H) Buy Neurocrine Bio Neurocrine price target raised to $128 from $114 at Citi ///////////////////////////////// GBA //////////////////////////////////
Neurocrine Biosciences, Inc. (NBIX) NasdaqGS - NasdaqGS Real Time Price 110.94+0.26(+0.23%) At close: 04:00PM EDT 112.93+1.99(+1.79%) <----------- Pre-Market:08:00AM EDT Quick thought: Always a take out candidate
WeWork Inc. (WE) NYSE - NYSE Delayed Price. 2.0900+0.0400(+1.95%) At close: 04:00PM EDT 2.1815+0.09(+4.38%)<----------- Quick thought: It makes sense especially as a GUMMY
Stoke Therapeutics, Inc. (STOK) NasdaqGS - NasdaqGS Real Time Price. 13.64+0.53(+4.04%) At close: 04:00PM EDT 14.10+0.46(+3.37%)<------------- Pre-Market:08:01AM EDT Quick thought: My guess this will run hard.- Get Stoked!